Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial-Reference-Cited by-同舟云学术

Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial

Published:2024-02 Issue: Volume:198 Page:113475
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Le Rhun Emilie^ORCID,Gorlia Thierry,Felsberg Jörg,Jongen Joost,Maurage Claude-Alain,Ducray François,Gramatzki Dorothee,Hau Peter,Chinot Olivier L.,Preusser Matthias^ORCID,Cartalat Stephanie,Roth Patrick,van den Bent Martin,Furtner Julia^ORCID,Collienne Maike^ORCID,Reifenberger Guido,Weller Michael

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference16 articles.

1. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood;Weller;Nat Rev Clin Oncol,2021

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions;Wen;Neuro-Oncol,2020

4. Where does O6 -methylguanine DNA methyltransferase promoter methylation assessment place temozolomide in the future standards of care for glioblastoma?;Weller;Cancer,2018

5. TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties;Goh;Leukemia,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK9 inhibitors for the treatment of solid tumors;Biochemical Pharmacology;2024-11

2. Corrigendum to “Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial” [Eur J Cancer 198 (2024) 113475];European Journal of Cancer;2024-06

3. CANCER THERAPY BY CYCLIN-DEPENDENT KINASE INHIBITORS (CDKIS): BENCH TO BEDSIDE;EXCLI J;2024